Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches

Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities

(2021) Alan Menter et al.   Dermatology and Therapy

Saliva Proteomics as Fluid Signature of Inflammatory and Immune-Mediated Skin Diseases

(2021) Anna Campanati et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review

(2020) Masahiro Kamata et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis

(2020) Sofie Vaengebjerg et al.   JAMA Dermatology

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications

(2020) Esther von Stebut et al.   Frontiers in Immunology

Practical recommendations for systemic treatment in psoriasis in case of coexisting inflammatory, neurologic, infectious or malignant disorders (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 2)

(2020) J.L.W. Lambert et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA‐PSO: Belgian Evidence‐based Treatment Advice in Psoriasis; part 1)

(2020) J.L.W. Lambert et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriasis and Risk of Uveitis: A Systematic Review and Meta-Analysis

(2020) Chayada Chaiyabutr et al.   Biomed Research International

Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease

(2020) Bahez Gareb et al.   Pharmaceutics

Gut Microbiome in Psoriasis: An Updated Review

(2020) Mariusz Sikora et al.   Pathogens

Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases

(2020) Junjue Chen et al.   Frontiers in Aging Neuroscience

Re-Examining the Role of TNF in MS Pathogenesis and Therapy

(2020) Diego Fresegna et al.   Cells

IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors

(2020) Alessandra Nerviani et al.   ANNALS OF THE RHEUMATIC DISEASES

Psoriasis Pathogenesis and Treatment

(2019) Adriana Rendon et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Coronary artery plaque characteristics and treatment with biologic therapy in severe psoriasis: results from a prospective observational study

(2019) Youssef A Elnabawi et al.   CARDIOVASCULAR RESEARCH

Management of psoriasis as a systemic disease: What is the evidence?

(2019) N.J. Korman   BRITISH JOURNAL OF DERMATOLOGY

A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U trial)

(2019) J.M. Gelfand et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Does systemic treatment of psoriasis reduce the risk of comorbidities?

(2019) P. Gisondi   BRITISH JOURNAL OF DERMATOLOGY

Asthma and psoriasis: What do they have in common? IL-17A!

(2019) William W. Busse   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Change in body weight and body mass index in psoriasis patients receiving biologics: a systematic review and network meta-analysis

(2019) Ming-Ying Wu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis

(2019) Lazaros I. Sakkas et al.   Frontiers in Pharmacology

Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis

(2019) Anna Campanati et al.   Expert Opinion on Drug Metabolism & Toxicology

IL‐17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL‐25‐Driven Intestinal Inflammation

(2019) Julia Manasson et al.   Arthritis & Rheumatology

Efficacy of anti-IL-23 monotherapy versus combination therapy with anti-IL-17 in estrogen deficiency induced bone loss conditions

(2018) Priyanka Shukla et al.   BONE

Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors

(2018) Anna Campanati et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Scanning the Immunopathogenesis of Psoriasis

(2018) Andrea Chiricozzi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR)

(2018) Bruce Strober et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

CME Part I Psoriasis: Which Therapy for Which Patient Psoriasis comorbidities and preferred systemic agents

(2018) Shivani B. Kaushik et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Studying the effect of systemic and biological drugs on intima-media thickness in patients suffering from moderate and severe psoriasis

(2018) A. Martinez-Lopez et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Anti-inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis

(2018) J.J. Wu et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Potential Immunological Links Between Psoriasis and Cardiovascular Disease

(2018) Aparna P. Sajja et al.   Frontiers in Immunology

Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences

(2018) Wolf-Henning Boehncke   Frontiers in Immunology

Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic

(2018) Michele Maria Luchetti et al.   CLINICAL RHEUMATOLOGY

A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis

(2018) Yihua Cai et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Impact of secukinumab on endothelial dysfunction and other cardiovascular disease parameters in psoriasis patients over 52 weeks

(2018) Esther von Stebut et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities

(2017) James G. Krueger et al.   EXPERIMENTAL DERMATOLOGY

Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn’s Disease: A Phase 2a Study

(2017) Bruce E. Sands et al.   GASTROENTEROLOGY

Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction

(2017) Maeve Lynch et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis

(2017) Fernanda Genre et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Effectiveness of etanercept in children with plaque psoriasis in real practice: a one-year multicenter retrospective study

(2017) Vito Di Lernia et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Psoriasis and comorbid diseases

(2017) Junko Takeshita et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate

(2017) Jashin J. Wu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)

(2017) Andrew Blauvelt et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Multiple sclerosis association with psoriasis: a large U.S. population, single centre, retrospective cross-sectional study

(2017) N. Guido et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial

(2017) Peter Nash et al.   LANCET

IL-17-differentiated macrophages secrete pro-inflammatory cytokines in response to oxidized low-density lipoprotein

(2017) María de la Paz Sánchez-Martínez et al.   Lipids in Health and Disease

Psoriatic Arthritis

(2017) Christopher T. Ritchlin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist

(2017) Luigi Barrea et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Tumor necrosis factor inhibitors in psoriatic arthritis

(2017) Santhi Mantravadi et al.   Expert Review of Clinical Pharmacology

Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases

(2017) Marwa Chehimi et al.   Journal of Clinical Medicine

Adalimumab Modulates Angiogenesis in Psoriatic Skin

(2017) A. Campanati et al.   European Journal of Inflammation

IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis

(2017) Nehal N. Mehta et al.   Scientific Reports

Cardiovascular Risk in Psoriasis: Current State of the Art

(2017) Giuseppe Dattilo et al.   Current Vascular Pharmacology

Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature

(2016) Jordi Gratacos-Masmitja et al.   ADVANCES IN THERAPY

Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis

(2016) K.F. Hjuler et al.   BRITISH JOURNAL OF DERMATOLOGY

The Inflammatory Response in Psoriasis: a Comprehensive Review

(2016) Yaxiong Deng et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Comorbidities in rheumatoid arthritis

(2016) Maxime Dougados   CURRENT OPINION IN RHEUMATOLOGY

Free fatty acids sensitize dendritic cells to amplify TH1/TH17-immune responses

(2016) Kristin Stelzner et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Patients with Refractory Crohnʼs Disease Successfully Treated with Ustekinumab

(2016) Kimberly A. Harris et al.   INFLAMMATORY BOWEL DISEASES

Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study

(2016) Eva Havrdová et al.   JOURNAL OF NEUROLOGY

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

(2016) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Keratinocytes contribute intrinsically to psoriasis upon loss ofTnip1function

(2016) Sirish K. Ippagunta et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Update on TNF Inhibitors

(2016) Francisco A. Kerdel et al.   SEMINARS IN CUTANEOUS MEDICINE AND SURGERY

Evaluation of cutaneous surface parameters in psoriatic patients

(2016) S. P. Cannavò et al.   SKIN RESEARCH AND TECHNOLOGY

Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis

(2016) Francesco Ciccia et al.   Arthritis & Rheumatology

Brief Report: CXCL10 Is a Possible Biomarker for the Development of Psoriatic Arthritis Among Patients With Psoriasis

(2016) Fatima Abji et al.   Arthritis & Rheumatology

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

(2016) Laura C. Coates et al.   Arthritis & Rheumatology

Comorbidity in inflammatory bowel disease

(2016) Antonio López San Román   WORLD JOURNAL OF GASTROENTEROLOGY

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

(2015) L Gossec et al.   ANNALS OF THE RHEUMATIC DISEASES

Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients

(2015) B.B. Jones et al.   BRITISH JOURNAL OF DERMATOLOGY

An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17

(2015) Lynda Grine et al.   CYTOKINE & GROWTH FACTOR REVIEWS

How effective is ustekinumab in controlling psoriatic arthritis?

(2015) Claudio Bonifati et al.   Dermatologic Therapy

Psoriasis and polycystic ovary syndrome: a new link in different phenotypes

(2015) Francesca Moro et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage

(2015) Xinyang Song et al.   IMMUNITY

Gut-Busters: IL-17 Ain’t Afraid of No IL-23

(2015) Natasha Whibley et al.   IMMUNITY

Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation

(2015) Joseph R. Maxwell et al.   IMMUNITY

Humanized anti–IFN-γ (HuZAF) in the treatment of psoriasis

(2015) Jamie L. Harden et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics

(2015) Akihiko Asahina et al.   JOURNAL OF DERMATOLOGY

The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study among Dermatological Out-Patients in 13 European Countries

(2015) Florence J. Dalgard et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink

(2015) Rosa Parisi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Homocysteine plasma levels in psoriasis patients: our experience and review of the literature

(2015) M. Giannoni et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriasis

(2015) Wolf-Henning Boehncke et al.   LANCET

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

(2015) Philip J. Mease et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neutrophil-macrophage communication in inflammation and atherosclerosis

(2015) M. Nahrendorf et al.   SCIENCE

Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis

(2015) Jennifer Belasco et al.   Arthritis & Rheumatology

Brief Report: Enrichment of Activated Group 3 Innate Lymphoid Cells in Psoriatic Arthritis Synovial Fluid

(2015) Emmerik F. A. Leijten et al.   Arthritis & Rheumatology

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

(2014) Christopher Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES

T-Cell Profile in Adipose Tissue Is Associated With Insulin Resistance and Systemic Inflammation in Humans

(2014) Tracey McLaughlin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease

(2014) Susanne Karbach et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Involvement of the oral cavity in psoriasis: results of a clinical study

(2014) G. Ganzetti et al.   BRITISH JOURNAL OF DERMATOLOGY

Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper

(2014) G. Girolomoni et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink

(2014) E. Edson-Heredia et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

More than skin-deep: the many dimensions of the psoriatic disease

(2014) WH Boehncke et al.   SWISS MEDICAL WEEKLY

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)

(2013) P J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

(2013) Jonathan Kay et al.   ANNALS OF THE RHEUMATIC DISEASES

Biomarkers in psoriasis and psoriatic arthritis

(2013) Federica Villanova et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease

(2013) Mark T. Osterman et al.   Clinical Gastroenterology and Hepatology

Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients

(2013) Luisa Costa et al.   CLINICAL RHEUMATOLOGY

Association Between Specific Adipose Tissue CD4+ T-Cell Populations and Insulin Resistance in Obese Individuals

(2013) Elisa Fabbrini et al.   GASTROENTEROLOGY

Dermal Clusters of Mature Dendritic Cells and T Cells Are Associated with the CCL20/CCR6 Chemokine System in Chronic Psoriasis

(2013) Tae-Gyun Kim et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

(2013) Dominique Baeten et al.   LANCET

Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis – a systematic review

(2013) Inez Wens et al.   Multiple Sclerosis Journal

Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction

(2012) Tabassome Simon et al.   EUROPEAN HEART JOURNAL

Antimicrobial peptides in the pathogenesis of psoriasis

(2012) Shin MORIZANE et al.   JOURNAL OF DERMATOLOGY

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis

(2012) A. Campanati et al.   JOURNAL OF GASTROENTEROLOGY

Expanding the Psoriasis Disease Profile: Interrogation of the Skin and Serum of Patients with Moderate-to-Severe Psoriasis

(2012) Mayte Suárez-Fariñas et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells

(2012) Jonathan P Sherlock et al.   NATURE MEDICINE

Diagnosis and classification in spondyloarthritis: identifying a chameleon

(2012) Astrid van Tubergen et al.   Nature Reviews Rheumatology

Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases

(2012) Jason S. Knight et al.   Frontiers in Immunology

Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?

(2011) D. D. Gladman et al.   ANNALS OF THE RHEUMATIC DISEASES

Systemic and Vascular Inflammation in Patients With Moderate to Severe Psoriasis as Measured by [18F]-Fluorodeoxyglucose Positron Emission Tomography –Computed Tomography (FDG-PET/CT)

(2011) Nehal N. Mehta   ARCHIVES OF DERMATOLOGY

Role of Interleukin 17 in Inflammation, Atherosclerosis, and Vascular Function in Apolipoprotein E–Deficient Mice

(2011) Meena S. Madhur et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study

(2011) K. Abuabara et al.   BRITISH JOURNAL OF DERMATOLOGY

Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease

(2011) Y. Tang et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis

(2011) April W. Armstrong et al.   EXPERIMENTAL DERMATOLOGY

Association Between Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events

(2011) Caitriona Ryan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IL-23 Is Critical for Induction of Arthritis, Osteoclast Formation, and Maintenance of Bone Mass

(2011) I. E. Adamopoulos et al.   JOURNAL OF IMMUNOLOGY

Epidermal CCR6 + γδ T Cells Are Major Producers of IL-22 and IL-17 in a Murine Model of Psoriasiform Dermatitis

(2011) Tomotaka Mabuchi et al.   JOURNAL OF IMMUNOLOGY

Psoriasis and Other Complex Trait Dermatoses: From Loci to Functional Pathways

(2011) Francesca Capon et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Interferon-α-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12

(2011) Stefano M. Santini et al.   PLoS One

Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors

(2011) Armen Yuri Gasparyan et al.   RHEUMATOLOGY INTERNATIONAL

TNFα in myocardial ischemia/reperfusion, remodeling and heart failure

(2010) Petra Kleinbongard et al.   HEART FAILURE REVIEWS

Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons

(2010) Josh Gregorio et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis

(2010) Judilyn Fuentes-Duculan et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study

(2010) A. Langer-Gould et al.   Multiple Sclerosis Journal

Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis

(2010) V. Chandran et al.   RHEUMATOLOGY

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

(2009) Arthur Kavanaugh et al.   ARTHRITIS AND RHEUMATISM

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

(2009) N. N. Mehta et al.   EUROPEAN HEART JOURNAL

Obesity predisposes to Th17 bias

(2009) Shawn Winer et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Differential regulation of interleukin 17 and interferon   production in inflammatory bowel disease

(2009) L. Rovedatti et al.   GUT

Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases

(2009) Leanne M. Johnson-Huang et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

(2009) Soraya Taleb et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Molecular Dissection of Psoriasis: Integrating Genetics and Biology

(2009) James T. Elder et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis

(2009) Shinji Kagami et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis

(2008) B. Strober et al.   BRITISH JOURNAL OF DERMATOLOGY